Cite
HARVARD Citation
Hassebroek, A. et al. (2023). A hepatitis B virus core antigen‐based virus‐like particle vaccine expressing SARS‐CoV‐2 B and T cell epitopes induces epitope‐specific humoral and cell‐mediated immune responses but confers limited protection against SARS‐CoV‐2 infection. Journal of medical virology. 95 (2), p. n/a. [Online].